A Single and Multiple Dose Study of Canagliflozin in Healthy Volunteers
NCT01281579
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Canagliflozin 100 mg
DRUG:
Canagliflozin 50 mg
DRUG:
Canagliflozin 300 mg
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.